Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyocardial autologous bone marrow mononuclear cells for refractory angina
NL-OMON29227Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2005
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial in angina pectoris and cardiac ischemia comparing Autologous bone marrow-derived mononuclear cells with Placebo (2 arms). Primary endpoint: Change in myocardial perfusion. Started May 2005; status: active, not recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
angina pectoriscardiac ischemia
Beyond the preview
Go deeper on NL-OMON29227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29227.